🕒 Thursday 31 July 2025 Thu, 31 July 2025

580 Articles

Cardiex Cuts Costs, Raises $6.5M, Eyes Revenue Growth Amid Cash Burn

Cardiex Limited reported a $3 million cash outflow in Q4 2025 but is banking on cost reductions and new product sales to improve its financial footing. The company also secured $6.5 million through a capital raise to bolster its runway.
31 July
Ada Torres
Ada Torres

AVADA Group Boosts Cash Flow Amid NZ Strategic Review

AVADA Group Limited reported a strong quarter with positive operating cash flows and significant debt reduction, while initiating a strategic review of its New Zealand operations amid challenging market conditions.
31 July
Victor Sage
Victor Sage

RocketBoots Advances Sales Pipeline, Secures Strategic Stake Amid Rising Retail AI Demand

RocketBoots Limited has expanded its sales pipeline with five new customers covering over 8,550 locations and secured a strategic $1 million investment from Bombora Funds, positioning itself strongly in the growing AI retail technology market.
31 July
Sophie Babbage
Sophie Babbage

Manuka Resources Advances Cobar Basin Plan with $8M Raise and NZ Iron Sands Progress

Manuka Resources has launched an $8 million entitlement offer to fund its Cobar Basin production restart, updated reserves at its Wonawinta silver and Mt Boppy gold mines, and reported strong economics for its New Zealand Taranaki VTM iron sands project advancing through fast-track approvals.
31 July
Maxwell Dee
Maxwell Dee

Oldfields Navigates Working Capital Crunch Amid Strategic Shift

Oldfields Holdings reports constrained Q4 FY2025 sales due to limited working capital but signals a positive growth outlook for FY2026 following its strategic transformation and capital support.
31 July
Victor Sage
Victor Sage

NGS Nears Profitability Amid CVS Launch and Walmart Expansion

Nutritional Growth Solutions reports a 13.6% revenue dip in Q2 FY25 but completes major CVS rollout and expands Walmart product range, improving cash flow and inventory.
31 July
Victor Sage
Victor Sage

Triton Minerals Advances Aucu Project Amid $8.5M Legal Battle and Cash Preservation

Triton Minerals pushes forward with its Aucu Copper/Gold Project after securing exploration licenses, while navigating a protracted $8.5 million legal dispute over its Mozambique Graphite Assets sale and implementing austerity measures to safeguard cash.
31 July
Maxwell Dee
Maxwell Dee

Cyprium Metals Advances Nifty Restart and Secures Full Paterson Control

Cyprium Metals has made significant strides in its phased restart of the Nifty Copper Complex, targeting a final investment decision in Q3 2025, while consolidating 100% ownership of the Paterson Exploration Project after IGO's exit.
31 July
Maxwell Dee
Maxwell Dee

WGR Accelerates Gold Duke Production with New Milling Deal and Strong Economics

Western Gold Resources has signed a pivotal 24-month toll milling agreement, advancing its Gold Duke Project towards near-term production amid rising gold prices and a recent capital raise.
31 July
Maxwell Dee
Maxwell Dee

Cokal Secures $15M to Boost Indonesian Coal Projects Amid Market Slump

Cokal Limited has secured a strategic US$15 million debt facility to support infrastructure and coal production at its Indonesian BBM mine, while cautiously navigating weak market conditions with minimal production and resumed domestic shipments.
31 July
Maxwell Dee
Maxwell Dee

Bounty Oil and Gas Eyes Surat Basin Growth Amid Legal Hurdles Offshore

Bounty Oil and Gas reported $1.09 million in oil revenue for FY 2025, boosted reserves to 313,000 barrels, and plans to double production with Surat Basin operations starting late 2025. Meanwhile, a Federal Court challenge looms over its Sydney Basin offshore permit.
31 July
Maxwell Dee
Maxwell Dee

Pioneer Lithium Unveils High-Grade Uranium Finds Amid Lithium Pause

Pioneer Lithium advances uranium exploration with promising high-grade assays at Skull Creek, while pausing lithium activities amid market downturn. A recent $320,000 capital raise supports ongoing uranium projects in the US and Namibia.
31 July
Maxwell Dee
Maxwell Dee

REZ Advances Gold Production at East Menzies, Completes Strategic Asset Sale

Resources & Energy Group Limited (REZ) reports strong progress in gold production at East Menzies with two successful gold pours and a $1.1 million capital raise, while divesting its Mount Mackenzie asset to sharpen focus on Western Australia.
31 July
Maxwell Dee
Maxwell Dee

Wellnex Life Boosts Sales 22% in Q4, Secures $2.8M Debt to Fuel Growth

Wellnex Life Limited reported a robust Q4 FY25 with a 22% sales increase and positive operational cash flow, underpinning its strategic growth initiatives backed by new debt funding.
31 July
Ada Torres
Ada Torres

Admiralty Resources Navigates Q2 with $1.7M Cash and Nearly 7 Quarters Runway

Admiralty Resources NL reported a cash balance of $1.738 million at the end of June 2025, supported by financing facilities that provide nearly seven quarters of operational funding. The company’s latest cash flow report reveals ongoing investment in exploration alongside careful management of its loan facilities.
31 July
Maxwell Dee
Maxwell Dee

West Cobar Metals Advances WA Gold and NSW Copper-Antimony Projects with New Resource and Drilling Progress

West Cobar Metals has completed the acquisition of the Mystique Gold Project in Western Australia and reported a maiden inferred mineral resource at its Bulla Park copper-antimony deposit in New South Wales, while drilling assays from its Fraser Range copper-gold targets are pending.
31 July
Maxwell Dee
Maxwell Dee

Admiralty Advances Mariposa Iron Ore Project with Key Sales and Infrastructure Gains

Admiralty Resources NL reports steady progress at its Mariposa Iron Ore Project in Chile, securing a major sales contract and advancing critical infrastructure during Q2 2025.
31 July
Maxwell Dee
Maxwell Dee

Pacific Lime and Cement Accelerates PNG Projects with First Quicklime Sales and Strong Funding

Pacific Lime and Cement Limited has made significant strides in Papua New Guinea, rebranding and advancing key projects while initiating commercial quicklime shipments to Western Australia. The company’s robust cash position and community agreements set the stage for upcoming construction milestones.
31 July
Maxwell Dee
Maxwell Dee

I Synergy Boosts Capital and Eyes AI Future with Treasure Global MoU

I Synergy Group Limited has strengthened its equity base through multiple capital raises and entered a strategic AI collaboration framework with NASDAQ-listed Treasure Global Inc., signaling a pivot towards advanced technology infrastructure.
31 July
Sophie Babbage
Sophie Babbage

Quantum Graphite Advances Eyre Peninsula Hub Amid Financing and Exploration Progress

Quantum Graphite Limited has made significant strides in developing its Eyre Peninsula Graphite Hub, progressing detailed planning with government stakeholders and attracting new financiers for its Uley 2 project. Exploration and purification testwork updates promise to refine its resource and product quality outlook.
31 July
Maxwell Dee
Maxwell Dee

Tryptamine Therapeutics Launches Groundbreaking Trial for Binge Eating Disorder

Tryptamine Therapeutics has initiated the first-ever clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with patient dosing set to begin shortly and results expected by year-end.
31 July
Ada Torres
Ada Torres

Adherium Surges 30% in US Patient Growth, Raises $4.5M to Fuel Expansion

Adherium Limited reports a robust 30% increase in US remote patient monitoring users and closes a $4.5 million capital raise, positioning itself for accelerated growth under new leadership.
31 July
Ada Torres
Ada Torres

HPP Boosts Cash to A$5.77M, Eyes Shareholder Returns and New Deals

Health and Plant Protein Group Ltd (HPP) ended FY25 Q4 with a strong cash position following a significant IRS payment, while signaling plans for shareholder returns and confidential corporate opportunities.
31 July
Victor Sage
Victor Sage

Vectus Validates Fibrosis Drug Safety, Eyes Licensing Deals in China and Beyond

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.
31 July
Ada Torres
Ada Torres